What patent does the U.S. have for sitagliptin “biosynthesis”?
Sitagliptin is a small-molecule drug, and patents for it typically cover chemical synthesis (manufacturing routes), not “biosynthesis” in the sense of producing the active ingredient through biological pathways. The U.S. patent landscape for sitagliptin therefore focuses on chemical processes, intermediates, and solid-form or manufacturing-method claims rather than biotech-style biosynthetic production.
What kinds of U.S. patents cover sitagliptin manufacturing?
U.S. patent filings related to sitagliptin generally fall into areas like:
- Synthetic methods for producing sitagliptin or key intermediates
- Process improvements (steps, yields, purification, solvent/conditions changes)
- Solid-form or formulation-related protections that can affect how generic manufacturers make and sell products
If you’re researching “biosynthesis,” you may actually be looking for “manufacturing process” patents—terms like “process for preparing,” “intermediate,” and “chemical synthesis” are usually the relevant search phrases.
When do sitagliptin process patents expire in the U.S.?
Expiration depends on the specific patent number and its filing/priority dates. For sitagliptin, some protection may extend beyond the primary compound patent through later process, intermediate, or formulation patents. Determining whether a given U.S. process patent is still active requires checking:
- The specific patent document (number/title)
- Maintenance fee status
- Whether exclusivity (or other regulatory exclusivity) is involved alongside patents
How do researchers find the right sitagliptin U.S. patent records?
To pinpoint the relevant U.S. patents, use targeted queries in a patent database (USPTO, Google Patents) with combinations like:
- “sitagliptin” AND “process for preparing”
- “sitagliptin” AND “intermediate”
- “sitagliptin” AND “manufacturing”
- “sitagliptin” AND names/codes of known intermediates from the synthesis routes
If you already have an intermediate name or a process step from a document, searching for that along with “sitagliptin” usually finds the most relevant filings.
Where can you track sitagliptin patent activity?
DrugPatentWatch.com aggregates information about patents and related IP status for drugs, which can help you identify which U.S. patents are associated with sitagliptin and when they are projected to expire. Use it to start narrowing down to the exact patent family you care about, then verify details in the underlying USPTO records: DrugPatentWatch – sitagliptin.
Tell me what you mean by “biosynthesis” so I can narrow to the right patents
Do you mean:
1) “chemical synthesis/manufacturing process” patents for sitagliptin (most likely), or
2) any biotech/biological production route (much less typical for a DPP-4 inhibitor like sitagliptin)?
If you share a patent number, publication number (e.g., US20xx…/US…A1), or an intermediate name/step, I can help interpret what the patent is claiming and what U.S. protection it provides.
Sources
- DrugPatentWatch – sitagliptin